Zobrazeno 1 - 10
of 29
pro vyhledávání: '"Currier, Judith S."'
Autor:
LaVange L; University of North Carolina, Chapel Hill, North Carolina (L.L.)., Adam SJ; Foundation for the National Institutes of Health, North Bethesda, Maryland (S.J.A.)., Currier JS; University of California, Los Angeles, Los Angeles, California (J.S.C.)., Higgs ES; National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland (E.S.H., S.W.R.)., Reineck LA; National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland (L.A.R.)., Hughes EA; Novartis Pharma, Basel, Switzerland (E.A.H.)., Read SW; National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland (E.S.H., S.W.R.).
Publikováno v:
Annals of internal medicine [Ann Intern Med] 2021 Sep; Vol. 174 (9), pp. 1293-1300. Date of Electronic Publication: 2021 Jun 29.
Autor:
Thio CL; aJohns Hopkins University, Baltimore, Maryland bHarvard School of Public Health, Boston, Massachusetts, USA cYRG Centre for AIDS Research and Education, Voluntary Health Services Hospital Campus, Taramani, Chennai dNational AIDS Research Institute-ICMR, Pune, India eUniversity of Zimbabwe Clinical Research Centre, College of Health Sciences, Harare, Zimbabwe fCollege of Medicine, Johns Hopkins Research Project, Department of Medicine, Blantyre, Malawi gNelson R Mandela School of Medicine, University of KwaZulu-Natal, Glenwood, South Africa hUniversity of Colorado School of Medicine, Aurora, Colorado iBrigham and Women's Hospital, Boston, Massachusetts jUCLA David Geffen School of Medicine, Los Angeles, California, USA., Smeaton L, Hollabaugh K, Saulynas M, Hwang H, Saravanan S, Kulkarni S, Hakim J, Nyirenda M, Iqbal HS, Lalloo UG, Campbell TB, Lockman S, Currier JS
Publikováno v:
AIDS (London, England) [AIDS] 2015 Jun 19; Vol. 29 (10), pp. 1173-82.
Autor:
Luetkemeyer AF; University of California San Francisco and San Francisco General Hospital, San Francisco, CA, USA., Havlir DV; University of California San Francisco and San Francisco General Hospital, San Francisco, CA, USA., Currier JS; University of California Los Angeles, Los Angeles, CA, USA.
Publikováno v:
Topics in antiviral medicine [Top Antivir Med] 2014 May; Vol. 22 (2), pp. 602-15.
Autor:
Luetkemeyer AF; University of California San Francisco, San Francisco, CA, USA., Havlir DV, Currier JS
Publikováno v:
Topics in antiviral medicine [Top Antivir Med] 2013 Apr-May; Vol. 21 (2), pp. 62-74.
Autor:
Thio CL; Johns Hopkins University, Baltimore, Maryland 21205, USA. cthio@jhmi.edu, Smeaton L, Saulynas M, Hwang H, Saravanan S, Kulkarni S, Hakim J, Nyirenda M, Iqbal HS, Lalloo UG, Mehta AS, Hollabaugh K, Campbell TB, Lockman S, Currier JS
Publikováno v:
AIDS (London, England) [AIDS] 2013 Jan 14; Vol. 27 (2), pp. 191-201.
Publikováno v:
Topics in antiviral medicine [Top Antivir Med] 2012 Jun-Jul; Vol. 20 (2), pp. 48-60.
Autor:
Boltz VF; National Cancer Institute, Frederick, MD 21702, USA., Zheng Y, Lockman S, Hong F, Halvas EK, McIntyre J, Currier JS, Chibowa MC, Kanyama C, Nair A, Owino-Ong'or W, Hughes M, Coffin JM, Mellors JW
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America [Proc Natl Acad Sci U S A] 2011 May 31; Vol. 108 (22), pp. 9202-7. Date of Electronic Publication: 2011 May 16.
Autor:
Lederman HM; Eudowood Division of Pediatric Allergy and Immunology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA. hlederm1@jhem.jhmi.edu, Williams PL, Wu JW, Evans TG, Cohn SE, McCutchan JA, Koletar SL, Hafner R, Connick E, Valentine FT, McElrath MJ, Roberts NJ Jr, Currier JS
Publikováno v:
The Journal of infectious diseases [J Infect Dis] 2003 Dec 15; Vol. 188 (12), pp. 1794-803. Date of Electronic Publication: 2003 Dec 08.
Autor:
LaVange, Lisa, Adam, Stacey J, Currier, Judith S, Higgs, Elizabeth S, Reineck, Lora A, Hughes, Eric A, Read, Sarah W, ACTIV Therapeutics-Clinical Working Group
Publikováno v:
Annals of internal medicine, vol 174, iss 9
Working in an unprecedented time frame, the Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV) public-private partnership developed and launched 9 master protocols between 14 April 2020 and 31 May 2021 to allow for the coordinated a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_______325::78992259da5af20da183bcdaac004184
https://escholarship.org/uc/item/69v0p03f
https://escholarship.org/uc/item/69v0p03f
Publikováno v:
Topics in antiviral medicine, vol 22, iss 2
The remarkable advances in interferon-sparing, all-oral hepatitis C virus (HCV) treatment were a highlight of the 2014 Conference on Retroviruses and Opportunistic Infections (CROI). The backbone of the nucleotide inhibitor sofosbuvir and the nonstru
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::cf72cc8c4a20fd3aeb2fec476e74c150
https://europepmc.org/articles/PMC6148912/
https://europepmc.org/articles/PMC6148912/